Literature DB >> 35725937

Association of tumor size and surgical approach with oncological outcomes and overall survival in patients with adrenocortical carcinoma.

Kevin B Ginsburg1, Alberto A Castro Bigalli2, Jared P Schober2, David Perlman3, Elizabeth A Handorf4, David Y T Chen2, Richard E Greenberg2, Rosalia Viterbo2, Robert G Uzzo2, Alexander Kutikov2, Marc C Smaldone2, Andres F Correa2.   

Abstract

OBJECTIVES: To investigate the association of surgical approach with outcomes in patients with adrenocortical carcinomas smaller and larger than 6 cm in size.
METHODS: We reviewed the national cancer database for patients undergoing minimally invasive adrenalectomy (MIA) and open adrenalectomy (OA) from 2010 to 2017. To adjust for differences between patients undergoing MIA and OA, we performed propensity score matching within each size strata of ≤6 cm, 6.1 to 10 cm, and 10.1 to 20 cm. We fit generalized estmiating equations with a logit link function to assess for the association of surgical approach with positive surgical margins and a Cox proportional hazards model to assess for the association of surgical approach with overall survival.
RESULTS: We identified 364 patients that underwent MIA (182) and OA (182) in the matched cohort.  We noted 21% and 18% of patients undergoing MIA and OA had a positive surgical margin, respectively. We did not identify a significant association between surgical approach and positive surgical margins in the cohort as a whole or within each of strata. Furthermore, we did not appreciate a significant association between surgical approach and overall survival in the cohort as a whole or within each size strata.
CONCLUSION: In the National Cancer Database, patients undergoing MIA had similar positive surgical margins and overall survival compared with OA for masses ≤6 cm, 6.1 to 10cm, and >10 cm in size. Patients undergoing MIA should be carefully selected with surgical oncologic integrity being the primary determinants of surgical approach.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenocoritcal carcinoma; Laparoscopy; Margins of excision; Survival

Mesh:

Year:  2022        PMID: 35725937      PMCID: PMC9569182          DOI: 10.1016/j.urolonc.2022.05.021

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   2.954


  22 in total

1.  Surgical quality of minimally invasive adrenalectomy for adrenocortical carcinoma: a contemporary analysis using the National Cancer Database.

Authors:  Matthew J Maurice; Matthew J Bream; Simon P Kim; Robert Abouassaly
Journal:  BJU Int       Date:  2016-09-01       Impact factor: 5.588

2.  Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.

Authors:  Kelly T Huynh; David Y Lee; Briana J Lau; Devin C Flaherty; JiHey Lee; Melanie Goldfarb
Journal:  J Am Coll Surg       Date:  2016-05-26       Impact factor: 6.113

3.  Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients.

Authors:  David Brix; Bruno Allolio; Wiebke Fenske; Ayman Agha; Henning Dralle; Christian Jurowich; Peter Langer; Thomas Mussack; Christoph Nies; Hubertus Riedmiller; Martin Spahn; Dirk Weismann; Stefanie Hahner; Martin Fassnacht
Journal:  Eur Urol       Date:  2010-06-22       Impact factor: 20.096

4.  Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients.

Authors:  Christina W Lee; Ahmed I Salem; David F Schneider; Glen E Leverson; Thuy B Tran; George A Poultsides; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Lawrence Shirley; Ryan C Fields; Linda X Jin; Timothy M Pawlik; Jason D Prescott; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; Sharon M Weber
Journal:  J Gastrointest Surg       Date:  2016-10-21       Impact factor: 3.452

5.  Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer.

Authors:  Francesco Porpiglia; Cristian Fiori; Fulvia Daffara; Barbara Zaggia; Enrico Bollito; Marco Volante; Alfredo Berruti; Massimo Terzolo
Journal:  Eur Urol       Date:  2010-01-26       Impact factor: 20.096

6.  Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.

Authors:  Karl Y Bilimoria; Wen T Shen; Dina Elaraj; David J Bentrem; David J Winchester; Electron Kebebew; Cord Sturgeon
Journal:  Cancer       Date:  2008-12-01       Impact factor: 6.860

7.  European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

Authors:  Martin Fassnacht; Olaf Dekkers; Tobias Else; Eric Baudin; Alfredo Berruti; Ronald de Krijger; Harm Haak; Radu Mihai; Guillaume Assie; Massimo Terzolo
Journal:  Eur J Endocrinol       Date:  2018-10-01       Impact factor: 6.664

Review 8.  Surgical Management of Adrenocortical Carcinoma: Impact of Laparoscopic Approach, Lymphadenectomy, and Surgical Volume on Outcomes-A Systematic Review and Meta-analysis of the Current Literature.

Authors:  Johan Langenhuijsen; Alison Birtle; Tobias Klatte; Francesco Porpiglia; Marc-Oliver Timsit
Journal:  Eur Urol Focus       Date:  2015-12-24

9.  Identification of oncological characteristics associated with improved overall survival in patients with adrenocortical carcinoma treated with adjuvant radiation therapy: Insights from the National Cancer Database.

Authors:  Kevin B Ginsburg; Akhil A Chandra; Jared P Schober; Elizabeth A Handorf; Robert G Uzzo; Richard E Greenberg; David Yt Chen; Rosalia Viterbo; Marc C Smaldone; Alexander Kutikov; Mark A Hallman; Andres F Correa
Journal:  Urol Oncol       Date:  2021-07-21       Impact factor: 3.498

10.  The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.

Authors:  Karl Y Bilimoria; Andrew K Stewart; David P Winchester; Clifford Y Ko
Journal:  Ann Surg Oncol       Date:  2008-01-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.